Clinical and histopathological tumour progression in ECL cell carcinoids ('ECLomas')

APMIS

Volumn 107, Issue 12, 1999, Pages 1085-1092

  Qvigstad, Gunnar ^a   Falkmer, Sture ^a   Westre, Bjørn ^b   Waldum, Helge L ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Møre and Romsdal Health Trust   (Norway)

Author keywords

Argyrophilia; Enterochromaffin like cell; Gastric carcinoids; Hypergastrinemia; Immunohistochemistry; Neoplastic cell transformation; Neuroendocrine cell markers; Tumour progression; Type A chronic atrophic gastritis; Tyramide signal amplification

Indexed keywords

CHROMOGRANIN A; GASTRIN; HISTIDINE DECARBOXYLASE; KI 67 ANTIGEN; SEROTONIN; TYRAMINE;

AGED; ARGYROPHILIA; ARTICLE; CARCINOID; CASE REPORT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENTEROCHROMAFFIN CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGASTRINEMIA; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; NEUROSECRETORY CELL; PRIORITY JOURNAL; SKIN METASTASIS; TOTAL STOMACH RESECTION; TUMOR GROWTH;

EID: 0033388447     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01513.x     Document Type: Article

References (30)

1. 1 Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985;88: 638-48.
2. 2. Solcia E, Bordi C, Creutzfeldt W, Dayal Y, Dayan AD, Falkmer S, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988;41:185-200.
3. 3. Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol 1990;14: 503-13.
4. 4. Lönroth H, Håkanson R, Lundell L, Sundler F. Histamine containing endocrine cells in the human stomach. Gut 1990;31:383-8.
5. 5. Carney JA, Go VL, Fairbanks VF, Moore SB, Alport EC, Nora FE. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med 1983;99:761-6.
6. 6. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994-1006.
7. 7. Waldum HL, Sandvik AK, Idle JR. Gastrin is the most important factor in ECL tumorigenesis. Gastroenterology 1998;114:1113-5.
8. 8. Chejfec G, Gould VE. Malignant gastric neuroendocrinomas. Ultrastructural and biochemical characterization of their secretory activity. Hum Pathol 1977;8:433-40.
9. 9. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 1999;116:532-42.
10. 10. Rappel S, Altendorf-Hofmann A, Stolte M. Prognosis of gastric carcinoid tumours. Digestion 1995;56:455-62.
11. 11. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992;40:1457-63.
12. 12. Sevier AC, Munger BL. A silver method for paraffin sections of neural tissue. J Neuropathol Exp Neurol 1965;24:130-5.
13. 13. Kleveland PM, Haugen SE, Waldum HL. The preparation of bioactive 1251-gastrin, using Iodo-gen as oxidizing agent, and the use of this tracer in receptor studies. Scand J Gastroenterol 1985;20:569-76.
14. 14. Syversen U, Mignon M, Bonfils S, Kristensen A, Waldum HL. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol 1993;32:161-5.
15. 15. Solcia E, Fiocca R, Sessa F, Rindi G, Gianatti A, Cornaggia M, et al. Morphology and natural history of gastric endocrine tumors. In: Håkanson R, Sundler F, editors. The stomach as an endocrine organ. Amsterdam: Elsevier Science Publishers, 1991:473-98.
16. 16. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986;35 Suppl 1:42-55.
17. 17. Mattsson H, Havu N, Brautigam J, Carlsson K, Lundell L, Carlsson E. Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat. Gastroenterology 1991;100:311-9.
18. 18. Waldum HL, Brenna E, Sandvik AK, Syversen U, Falkmer S. Hormones and carcinogenesis. Endocr Rel Canc 1998;5:45-8.
19. 19. Thomas RM, Baybick JH, Elsayed AM, Sobin LH. Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer 1994;73:2053-8.
20. 20. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-29.
21. 21. Waldum HL, Rørvik H, Brenna E. The gastrointestinal tract and the lungs. Similarities with particular emphasis on the neuroendocrine cells. Sarcoidosis Vase Diffuse Lung Dis 1996;13:63-5.
22. 22. Onuki N, Wistuba II, Travis WD, Virmani AK, Yashima K, Brambilla E, et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 1999;85:600-7.
23. 23. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396: 643-9.
24. 24. Poynter D, Pick CR, Harcourt RA, Selway SA, Ainge G, Harman IW, et al. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut 1985;26:1284-95.
25. 25. Creutzfeldt W, Arnold R, Creutzfeldt C, Deuticke U, Frerichs H, Track NS. Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia 1973;9:217-31.
26. 26. McNicol AM, Richmond JA. Optimizing immunohistochemistry: antigen retrieval and signal amplification. Histopathology 1998;32:97-103.
27. 27. Yamashina M, Flinner RA. Concurrent occurrence of adenocarcinoma and carcinoid tumor in the stomach: a composite tumor or collision tumors? Am J Clin Pathol 1985;83:233-6.
28. 28. Waldum HL, Aase S, Kvetnoi I, Brenna E, Sandvik AK, Syversen U, et al. Neuroendocrine differentiation in human gastric carcinomas. Cancer 1998;83:435-44.
29. 29. Godwin JD. Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975;36:560-9.
30. 30. Haga Y, Nakatsura T, Shibata Y, Sameshima H, Nakamura Y, Tanimura M, et al. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Dig Dis Sci 1998;43:253-7.